GH1 and metabolic dysfunction-associated steatohepatitis: In addition, growth hormone (GH) and insulin growth factor-1 (IGF-1) may be decreased in NAFLD/NASH, which may contribute to the progression of sarcopenia, since IGF-1 produced in the liver has a muscle-retaining effect [55].